The treatment journey of a patient with multidrug-resistant tuberculosis in South Africa: is it patient-centred?

Int J Tuberc Lung Dis. 2013 Oct;17(10 Suppl 1):56-59. doi: 10.5588/ijtld.13.0101.

Abstract

To improve the treatment of patients co-infected with multidrug-resistant tuberculosis (MDR-TB) and the human immunodeficiency virus, we measured the relationship between treatment outcomes and hospital performance at four decentralised MDR-TB sites in South Africa. We describe hospital performance from the patient's perspective by the use of a graphic that visually represents a patient's treatment journey. The graphic was used to report study findings to study sites and as a catalyst for a quality improvement process.

Publication types

  • Case Reports
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antitubercular Agents / therapeutic use*
  • Delivery of Health Care / organization & administration*
  • Delivery of Health Care / standards
  • Female
  • HIV Infections / complications
  • HIV Infections / therapy*
  • Humans
  • Patient-Centered Care / organization & administration
  • Quality of Health Care
  • South Africa / epidemiology
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / therapy*

Substances

  • Antitubercular Agents